Women: latest news

Women resources

Women features

Women in your own words

Women news from aidsmap

More news

Women news selected from other sources

  • Québec researchers call for interventions to support HIV-positive mothers

    A team of researchers at several universities and clinics in Montreal conducted a study to explore issues related to healthcare access and mental health among HIV-positive mothers. In detailed interviews with 100 mothers, the researchers uncovered several issues that affected the women’s mental health. The team made recommendations for doctors, nurses and other care providers, which, if implemented, could greatly improve the mental health and wellbeing of HIV-positive women who have children.

    14 April 2015 | CATIE
  • Zimbabwe’s female condom success story takes new form

    Zimbabwe’s Ministry of Health is currently gathering evidence on acceptance of a new Cupid Female Condom before rolling it out.

    13 April 2015 | Key Correspondents
  • Uganda: women and girls bear burden of HIV caregiving

    James Odong explores how the burden of caregiving falls heavily on girls, affecting their quality of life and education opportunities, as well as bringing added vulnerabilities.

    07 April 2015 | Key Correspondents
  • Predictors of HIV-related peripheral neuropathy in the modern era

    Researchers at major clinical centres in the U.S. have collaborated to study potential causes of peripheral neuropathy (PN) among HIV-positive people in the modern era. They recruited about 500 people who were free from PN and monitored them for an average of two years, performing extensive assessments. Taking into account many issues, statistical analysis found that there were several factors associated with an increased risk for PN.

    01 April 2015 | CATIE
  • Menopause linked to decreased anti-HIV activity

    Postmenopausal women’s cervicovaginal fluid had lower anti-HIV-1 activity than premenopausal women. Timing of menstrual cycle and hormonal contraception were not associated with differences in activity against HSV or HIV.

    30 March 2015 | 2 Minute Medicine
  • Partners launch phase 2 safety study of a long-acting injectable to prevent HIV

    PATH, in collaboration with the US National Institutes of Health (NIH) and the HIV Prevention Trials Network (HPTN), has launched a new study to test the safety and acceptability of a long-acting injectable formulation of the proven antiretroviral drug rilpivirine (TMC278) as a pre-exposure prophylaxis (PrEP) against HIV.

    06 March 2015 | PATH
  • Are women PrEPared?

    Can PreP just be provided to men who have sex with men in the UK? What about others? What about other vulnerable populations, such as black women and migrants? What about trans women? All the data we have here in the UK is about men who have sex with men, and this worries me.

    02 March 2015 | Speaking Up! (blog)
  • Failed Trial in Africa Raises Questions About How to Test HIV Drugs

    The failure of the VOICE trial of H.I.V.-prevention methods in Africa — and the elaborate deceptions employed by the women in it — have opened an ethical debate about how to run such studies in poor countries and have already changed the design of some that are now underway.

    05 February 2015 | New York Times
  • Uganda: High Hopes Ahead of Microbicide Trial Results

    HIV/Aids researchers are anticipating positive results from a large-scale trial assessing the efficacy of a vaginal microbicide gel in preventing HIV infection in women.

    21 January 2015 | AllAfrica.com
  • PrEP works in women using injectable hormonal contraceptives and in their male sex partners

    Preexposure prophylaxis (PrEP) with tenofovir or tenofovir/emtricitabine proved as effective in women using the injectable hormonal contraceptive depot medroxyprogesterone acetate (DMPA) as in women using no hormonal contraceptive. The same proved true of men whose female sex partners were using DMPA.

    07 January 2015 | International AIDS Society
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.